This HTML5 document contains 112 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n8	https://w3id.org/oc/corpus/br/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n10	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
n12	http://dx.doi.org/10.1161/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q28236175

rdf:type

wikibase:Item

schema:description

articol științific научни чланак επιστημονικό άρθρο artigo científico מאמר מדעי мақолаи илмӣ artigo científico mokslinis straipsnis scientific article (publication date: March 2005) научна статия vedecký článok (publikovaný 2005/03/01) 2005年論文 bilimsel makale 2005 թվականի մարտին հրատարակված գիտական հոդված 2005年論文 wissenschaftlicher Artikel wetenschappelijk artikel (gepubliceerd op 2005/03/01) artikull shkencor ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2005年論文 artículu científicu espublizáu en 2005 teaduslik artikkel мақолаи илмӣ artigo científico artykuł naukowy artículo científico publicado en 2005 vetenskaplig artikel 2005年の論文 2005年论文 article científic 2005年论文 บทความทางวิทยาศาสตร์ научная статья articolo scientifico 2005年论文 vitenskapelig artikkel bài báo khoa học article scientifique مقالة علمية (نشرت في مارس 2005) 2005年論文 наукова стаття, опублікована в березні 2005 artikulong pang-agham videnskabelig artikel article scientific 2005 թուականի Մարտին հրատարակուած գիտական յօդուած tudományos cikk naučni članak 2005年论文 2005년 논문 tieteellinen artikkeli 2005 nî lūn-bûn научни чланак 2005年论文 vitskapeleg artikkel vědecký článek publikovaný v roce 2005 2005年论文 scienca artikolo 2005年論文 სამეცნიერო სტატია

p:P577

wds:Q28236175-A4E2F0FF-5765-4D73-8347-CB8F05C62CF9

wdt:P577

2005-03-01T00:00:00Z

p:P407

wds:Q28236175-DEC18089-39A3-45BA-95BE-B721E74974D4

wdt:P407

wd:Q1860

p:P2093

wds:Q28236175-D74A6BFB-5504-4FA7-B46C-105FAF3CF022 wds:Q28236175-55F13F73-B139-48F9-B7F6-05C3686D6CD2 wds:Q28236175-FED89ADF-427B-438A-B73E-D468194DE677 wds:Q28236175-96DEBDCF-BF76-4377-988D-6E779DD72DC0 wds:Q28236175-A062C085-6CA3-4783-BCF8-541F2E9837D5

p:P3181

wds:Q28236175-6A768C7E-06F0-4739-91DC-14FAF8220AA4

wdtn:P3181

n8:4704627

wdt:P2093

Robert L Lins Juerg Nussberger Yanntong Chiang Alan H Gradman Martin P Bedigian

wdt:P3181

4704627

rdfs:label

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

skos:prefLabel

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

schema:name

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

p:P50

wds:Q28236175-1F9ACAB6-4579-4858-BD94-4035DA9698D1

wdt:P50

wd:Q57071845

p:P1476

wds:Q28236175-72E5D30F-6DAE-4901-958F-2D457E8A3132

wdt:P1476

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

p:P304

wds:Q28236175-3BB9AB11-3103-4ED1-B7EA-6A95FBA47C6B

wdt:P304

1012-8

p:P31

wds:Q28236175-17AD948D-50B7-4A27-8281-1AB6E2509906

wdt:P31

wd:Q13442814

p:P921

wds:Q28236175-004337CA-C1BB-4485-B634-2E8B949268B3 wds:Q28236175-37DE606F-77BF-4E1B-9995-758C4538A148

wdt:P921

wd:Q269829 wd:Q181600

p:P698

wds:Q28236175-E37F7E7B-1F40-4716-813B-1F43EA9F8BB1

wdtn:P698

n10:15723979

wdt:P698

15723979

p:P1433

wds:Q28236175-D04B928D-5992-4A35-94DC-35075A377CAA

wdt:P1433

wd:Q578091

p:P433

wds:Q28236175-FD620676-C942-4CFD-A284-91D307FD168B

p:P478

wds:Q28236175-D43C913B-1663-4D35-B462-C64B803FF003

wdt:P433

8

wdt:P478

111

p:P356

wds:Q28236175-2071AF0B-CB5A-42A2-8F93-F85692C851C7

wdtn:P356

n12:01.CIR.0000156466.02908.ED

wdt:P356

10.1161/01.CIR.0000156466.02908.ED

p:P5875

wds:Q28236175-07E94AD2-5A31-419B-BB13-9AA66318BE18

wdt:P5875

8009610